Extended	B:C0231449
versus	O
standard	O
pelvic	O
lymphadenectomy	I:C0193883
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
:	O
the	O
role	O
of	O
extended	O
template	O
as	O
an	O
independent	O
predictor	I:C0683956
of	O
lymph	O
node	I:C0024204
invasion	O
with	O
comparable	O
morbidity	O
burden	O
.	O

Extended	O
versus	O
standard	O
pelvic	B:C0193883
lymphadenectomy	I:C0193883
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
:	O
the	O
role	O
of	O
extended	O
template	O
as	O
an	O
independent	O
predictor	I:C0683956
of	O
lymph	O
node	I:C0024204
invasion	O
with	O
comparable	O
morbidity	O
burden	O
.	O

Extended	O
versus	O
standard	O
pelvic	O
lymphadenectomy	I:C0193883
during	O
robot	B:C4039115
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
:	O
the	O
role	O
of	O
extended	O
template	O
as	O
an	O
independent	O
predictor	I:C0683956
of	O
lymph	O
node	I:C0024204
invasion	O
with	O
comparable	O
morbidity	O
burden	O
.	O

Extended	O
versus	O
standard	O
pelvic	O
lymphadenectomy	I:C0193883
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
:	O
the	O
role	O
of	O
extended	B:C0231449
template	O
as	O
an	O
independent	O
predictor	I:C0683956
of	O
lymph	O
node	I:C0024204
invasion	O
with	O
comparable	O
morbidity	O
burden	O
.	O

Extended	O
versus	O
standard	O
pelvic	O
lymphadenectomy	I:C0193883
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
:	O
the	O
role	O
of	O
extended	O
template	O
as	O
an	O
independent	B:C0683956
predictor	I:C0683956
of	O
lymph	O
node	I:C0024204
invasion	O
with	O
comparable	O
morbidity	O
burden	O
.	O

Extended	O
versus	O
standard	O
pelvic	O
lymphadenectomy	I:C0193883
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
:	O
the	O
role	O
of	O
extended	O
template	O
as	O
an	O
independent	O
predictor	I:C0683956
of	O
lymph	B:C0024204
node	I:C0024204
invasion	O
with	O
comparable	O
morbidity	O
burden	O
.	O

Extended	O
versus	O
standard	O
pelvic	O
lymphadenectomy	I:C0193883
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
:	O
the	O
role	O
of	O
extended	O
template	O
as	O
an	O
independent	O
predictor	I:C0683956
of	O
lymph	O
node	I:C0024204
invasion	B:C1269955
with	O
comparable	O
morbidity	O
burden	O
.	O

To	O
assess	O
oncologic	B:C0205478
and	O
surgical	O
outcomes	O
in	O
patients	O
subjected	O
to	O
standard	O
(	O
S	O
)	O
versus	O
extended	O
(	O
extended	O
)	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
(	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
)	O
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
(	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
)	O
.	O

To	O
assess	O
oncologic	O
and	O
surgical	B:C0543467
outcomes	O
in	O
patients	O
subjected	O
to	O
standard	O
(	O
S	O
)	O
versus	O
extended	O
(	O
extended	O
)	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
(	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
)	O
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
(	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
)	O
.	O

To	O
assess	O
oncologic	O
and	O
surgical	O
outcomes	O
in	O
patients	O
subjected	O
to	O
standard	O
(	O
S	O
)	O
versus	O
extended	B:C0231449
(	O
extended	O
)	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
(	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
)	O
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
(	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
)	O
.	O

To	O
assess	O
oncologic	O
and	O
surgical	O
outcomes	O
in	O
patients	O
subjected	O
to	O
standard	O
(	O
S	O
)	O
versus	O
extended	O
(	O
extended	B:C0231449
)	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
(	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
)	O
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
(	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
)	O
.	O

To	O
assess	O
oncologic	O
and	O
surgical	O
outcomes	O
in	O
patients	O
subjected	O
to	O
standard	O
(	O
S	O
)	O
versus	O
extended	O
(	O
extended	O
)	O
pelvic	B:C0193883
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
(	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
)	O
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
(	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
)	O
.	O

To	O
assess	O
oncologic	O
and	O
surgical	O
outcomes	O
in	O
patients	O
subjected	O
to	O
standard	O
(	O
S	O
)	O
versus	O
extended	O
(	O
extended	O
)	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
(	O
pelvic	B:C0193883
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
)	O
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
(	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
)	O
.	O

To	O
assess	O
oncologic	O
and	O
surgical	O
outcomes	O
in	O
patients	O
subjected	O
to	O
standard	O
(	O
S	O
)	O
versus	O
extended	O
(	O
extended	O
)	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
(	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
)	O
during	O
robot	B:C4039115
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
(	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
)	O
.	O

To	O
assess	O
oncologic	O
and	O
surgical	O
outcomes	O
in	O
patients	O
subjected	O
to	O
standard	O
(	O
S	O
)	O
versus	O
extended	O
(	O
extended	O
)	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
(	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
)	O
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
(	O
robot	B:C4039115
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
)	O
.	O

From	O
February	O
2009	O
to	O
December	O
2015	O
a	O
total	O
of	O
184	O
consecutive	O
patients	O
underwent	O
robot	B:C4039115
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
and	O
either	O
standard	O
or	O
extended	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
for	O
localized	O
prostate	I:C0600139
cancer	I:C0600139
(	O
prostate	O
cancer	I:C0600139
)	O
.	O

From	O
February	O
2009	O
to	O
December	O
2015	O
a	O
total	O
of	O
184	O
consecutive	O
patients	O
underwent	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
and	O
either	O
standard	O
or	O
extended	B:C0231449
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
for	O
localized	O
prostate	I:C0600139
cancer	I:C0600139
(	O
prostate	O
cancer	I:C0600139
)	O
.	O

From	O
February	O
2009	O
to	O
December	O
2015	O
a	O
total	O
of	O
184	O
consecutive	O
patients	O
underwent	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
and	O
either	O
standard	O
or	O
extended	O
pelvic	B:C0193883
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
for	O
localized	O
prostate	I:C0600139
cancer	I:C0600139
(	O
prostate	O
cancer	I:C0600139
)	O
.	O

From	O
February	O
2009	O
to	O
December	O
2015	O
a	O
total	O
of	O
184	O
consecutive	O
patients	O
underwent	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
and	O
either	O
standard	O
or	O
extended	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
for	O
localized	B:C0600139
prostate	I:C0600139
cancer	I:C0600139
(	O
prostate	O
cancer	I:C0600139
)	O
.	O

From	O
February	O
2009	O
to	O
December	O
2015	O
a	O
total	O
of	O
184	O
consecutive	O
patients	O
underwent	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
and	O
either	O
standard	O
or	O
extended	O
pelvic	O
lymph	I:C0193883
node	I:C0193883
dissection	I:C0193883
for	O
localized	O
prostate	I:C0600139
cancer	I:C0600139
(	O
prostate	B:C0600139
cancer	I:C0600139
)	O
.	O

Descriptive	B:C0005544
statistics	I:C0005544
compared	O
clinical	O
and	O
pathological	O
variables	O
between	O
groups	O
.	O

Logistic	B:C0206031
regression	I:C0206031
identified	O
potential	O
predictors	O
of	O
lymph	O
node	I:C0024204
invasion	O
(	O
lymph	O
node	I:C1269955
invasion	I:C1269955
)	O
.	O

Logistic	O
regression	I:C0206031
identified	O
potential	O
predictors	O
of	O
lymph	B:C0024204
node	I:C0024204
invasion	O
(	O
lymph	O
node	I:C1269955
invasion	I:C1269955
)	O
.	O

Logistic	O
regression	I:C0206031
identified	O
potential	O
predictors	O
of	O
lymph	O
node	I:C0024204
invasion	B:C1269955
(	O
lymph	O
node	I:C1269955
invasion	I:C1269955
)	O
.	O

Logistic	O
regression	I:C0206031
identified	O
potential	O
predictors	O
of	O
lymph	O
node	I:C0024204
invasion	O
(	O
lymph	B:C1269955
node	I:C1269955
invasion	I:C1269955
)	O
.	O

No	O
significant	O
preoperative	O
differences	O
were	O
found	O
between	O
the	O
EPLND	B:C0193883
and	O
SPLND	O
groups	O
.	O

No	O
significant	O
preoperative	O
differences	O
were	O
found	O
between	O
the	O
EPLND	O
and	O
SPLND	B:C0193883
groups	O
.	O

No	O
difference	O
in	O
complication	B:C0009566
rates	O
was	O
observed	O
between	O
groups	O
.	O

No	O
group	O
differences	O
were	O
found	O
for	O
intraoperative	O
blood	B:C3163616
loss	I:C3163616
,	O
hospitalization	O
times	O
,	O
positive	O
surgical	I:C1709603
margins	I:C1709603
,	O
biochemical	O
recurrence	O
,	O
sexual	O
dysfunction	I:C0549622
or	O
need	O
for	O
adjuvant	O
therapy	I:C0677850
.	O

No	O
group	O
differences	O
were	O
found	O
for	O
intraoperative	O
blood	O
loss	I:C3163616
,	O
hospitalization	B:C0019993
times	O
,	O
positive	O
surgical	I:C1709603
margins	I:C1709603
,	O
biochemical	O
recurrence	O
,	O
sexual	O
dysfunction	I:C0549622
or	O
need	O
for	O
adjuvant	O
therapy	I:C0677850
.	O

No	O
group	O
differences	O
were	O
found	O
for	O
intraoperative	O
blood	O
loss	I:C3163616
,	O
hospitalization	O
times	O
,	O
positive	B:C1709603
surgical	I:C1709603
margins	I:C1709603
,	O
biochemical	O
recurrence	O
,	O
sexual	O
dysfunction	I:C0549622
or	O
need	O
for	O
adjuvant	O
therapy	I:C0677850
.	O

No	O
group	O
differences	O
were	O
found	O
for	O
intraoperative	O
blood	O
loss	I:C3163616
,	O
hospitalization	O
times	O
,	O
positive	O
surgical	I:C1709603
margins	I:C1709603
,	O
biochemical	O
recurrence	O
,	O
sexual	B:C0549622
dysfunction	I:C0549622
or	O
need	O
for	O
adjuvant	O
therapy	I:C0677850
.	O

No	O
group	O
differences	O
were	O
found	O
for	O
intraoperative	O
blood	O
loss	I:C3163616
,	O
hospitalization	O
times	O
,	O
positive	O
surgical	I:C1709603
margins	I:C1709603
,	O
biochemical	O
recurrence	O
,	O
sexual	O
dysfunction	I:C0549622
or	O
need	O
for	O
adjuvant	B:C0677850
therapy	I:C0677850
.	O

A	O
higher	O
median	O
range	O
of	O
LN	B:C0024204
yield	O
was	O
found	O
for	O
the	O
EPLND	O
compared	O
to	O
SPLND	O
cohort	O
(	O
22.5	O
vs	O
12.8	O
;	O
p<0.001	O
)	O
.	O

A	O
higher	O
median	O
range	O
of	O
LN	O
yield	O
was	O
found	O
for	O
the	O
EPLND	B:C0193883
compared	O
to	O
SPLND	O
cohort	O
(	O
22.5	O
vs	O
12.8	O
;	O
p<0.001	O
)	O
.	O

A	O
higher	O
median	O
range	O
of	O
LN	O
yield	O
was	O
found	O
for	O
the	O
EPLND	O
compared	O
to	O
SPLND	B:C0193883
cohort	O
(	O
22.5	O
vs	O
12.8	O
;	O
p<0.001	O
)	O
.	O

A	O
higher	O
median	O
range	O
of	O
LN	O
yield	O
was	O
found	O
for	O
the	O
EPLND	O
compared	O
to	O
SPLND	O
cohort	B:C0599755
(	O
22.5	O
vs	O
12.8	O
;	O
p<0.001	O
)	O
.	O

Of	O
the	O
36	O
patients	O
who	O
had	O
positive	B:C1446409
LNs	O
at	O
the	O
final	O
pathology	O
,	O
22	O
were	O
in	O
the	O
EPLND	O
group	O
and	O
14	O
in	O
the	O
SPLND	O
group	O
(	O
p<0.01	O
)	O
.	O

Of	O
the	O
36	O
patients	O
who	O
had	O
positive	O
LNs	B:C0024204
at	O
the	O
final	O
pathology	O
,	O
22	O
were	O
in	O
the	O
EPLND	O
group	O
and	O
14	O
in	O
the	O
SPLND	O
group	O
(	O
p<0.01	O
)	O
.	O

Of	O
the	O
36	O
patients	O
who	O
had	O
positive	O
LNs	O
at	O
the	O
final	O
pathology	B:C0030664
,	O
22	O
were	O
in	O
the	O
EPLND	O
group	O
and	O
14	O
in	O
the	O
SPLND	O
group	O
(	O
p<0.01	O
)	O
.	O

Of	O
the	O
36	O
patients	O
who	O
had	O
positive	O
LNs	O
at	O
the	O
final	O
pathology	O
,	O
22	O
were	O
in	O
the	O
EPLND	B:C0193883
group	O
and	O
14	O
in	O
the	O
SPLND	O
group	O
(	O
p<0.01	O
)	O
.	O

Of	O
the	O
36	O
patients	O
who	O
had	O
positive	O
LNs	O
at	O
the	O
final	O
pathology	O
,	O
22	O
were	O
in	O
the	O
EPLND	O
group	O
and	O
14	O
in	O
the	O
SPLND	B:C0193883
group	O
(	O
p<0.01	O
)	O
.	O

PSA	B:C0138741
,	O
clinical	O
stage	O
and	O
both	O
number	O
of	O
nodes	O
removed	O
and	O
EPLND	O
were	O
significant	O
univariable	O
predictors	I:C0683956
for	O
lymph	O
node	I:C1269955
invasion	I:C1269955
.	O

PSA	O
,	O
clinical	O
stage	O
and	O
both	O
number	O
of	O
nodes	B:C0024204
removed	O
and	O
EPLND	O
were	O
significant	O
univariable	O
predictors	I:C0683956
for	O
lymph	O
node	I:C1269955
invasion	I:C1269955
.	O

PSA	O
,	O
clinical	O
stage	O
and	O
both	O
number	O
of	O
nodes	O
removed	O
and	O
EPLND	B:C0193883
were	O
significant	O
univariable	O
predictors	I:C0683956
for	O
lymph	O
node	I:C1269955
invasion	I:C1269955
.	O

PSA	O
,	O
clinical	O
stage	O
and	O
both	O
number	O
of	O
nodes	O
removed	O
and	O
EPLND	O
were	O
significant	O
univariable	B:C0683956
predictors	I:C0683956
for	O
lymph	O
node	I:C1269955
invasion	I:C1269955
.	O

PSA	O
,	O
clinical	O
stage	O
and	O
both	O
number	O
of	O
nodes	O
removed	O
and	O
EPLND	O
were	O
significant	O
univariable	O
predictors	I:C0683956
for	O
lymph	B:C1269955
node	I:C1269955
invasion	I:C1269955
.	O

In	O
the	O
multivariable	B:C3161035
model	I:C3161035
,	O
PSA	O
,	O
clinical	O
stage	O
and	O
number	O
of	O
removed	O
nodes	O
were	O
independent	O
predictors	I:C0683956
of	O
lymph	O
node	I:C1269955
invasion	I:C1269955
.	O

In	O
the	O
multivariable	O
model	I:C3161035
,	O
PSA	B:C0138741
,	O
clinical	O
stage	O
and	O
number	O
of	O
removed	O
nodes	O
were	O
independent	O
predictors	I:C0683956
of	O
lymph	O
node	I:C1269955
invasion	I:C1269955
.	O

In	O
the	O
multivariable	O
model	I:C3161035
,	O
PSA	O
,	O
clinical	O
stage	O
and	O
number	O
of	O
removed	O
nodes	B:C0024204
were	O
independent	O
predictors	I:C0683956
of	O
lymph	O
node	I:C1269955
invasion	I:C1269955
.	O

In	O
the	O
multivariable	O
model	I:C3161035
,	O
PSA	O
,	O
clinical	O
stage	O
and	O
number	O
of	O
removed	O
nodes	O
were	O
independent	B:C0683956
predictors	I:C0683956
of	O
lymph	O
node	I:C1269955
invasion	I:C1269955
.	O

In	O
the	O
multivariable	O
model	I:C3161035
,	O
PSA	O
,	O
clinical	O
stage	O
and	O
number	O
of	O
removed	O
nodes	O
were	O
independent	O
predictors	I:C0683956
of	O
lymph	B:C1269955
node	I:C1269955
invasion	I:C1269955
.	O

EPLND	B:C0193883
was	O
an	O
independent	O
predictor	I:C0683956
of	O
lymph	O
node	I:C1269955
invasion	I:C1269955
after	O
accounting	O
for	O
PSA	O
,	O
clinical	O
stage	O
and	O
Gleason	O
Score	I:C3203027
stage	I:C3203027
.	O

EPLND	O
was	O
an	O
independent	B:C0683956
predictor	I:C0683956
of	O
lymph	O
node	I:C1269955
invasion	I:C1269955
after	O
accounting	O
for	O
PSA	O
,	O
clinical	O
stage	O
and	O
Gleason	O
Score	I:C3203027
stage	I:C3203027
.	O

EPLND	O
was	O
an	O
independent	O
predictor	I:C0683956
of	O
lymph	B:C1269955
node	I:C1269955
invasion	I:C1269955
after	O
accounting	O
for	O
PSA	O
,	O
clinical	O
stage	O
and	O
Gleason	O
Score	I:C3203027
stage	I:C3203027
.	O

EPLND	O
was	O
an	O
independent	O
predictor	I:C0683956
of	O
lymph	O
node	I:C1269955
invasion	I:C1269955
after	O
accounting	O
for	O
PSA	B:C0138741
,	O
clinical	O
stage	O
and	O
Gleason	O
Score	I:C3203027
stage	I:C3203027
.	O

EPLND	O
was	O
an	O
independent	O
predictor	I:C0683956
of	O
lymph	O
node	I:C1269955
invasion	I:C1269955
after	O
accounting	O
for	O
PSA	O
,	O
clinical	O
stage	O
and	O
Gleason	B:C3203027
Score	I:C3203027
stage	I:C3203027
.	O

EPLND	B:C0193883
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
is	O
safe	O
and	O
effective	O
.	O

EPLND	O
during	O
robot	B:C4039115
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
is	O
safe	O
and	O
effective	O
.	O

EPLND	O
during	O
robot	O
-	I:C4039115
assisted	I:C4039115
radical	I:C4039115
prostatectomy	I:C4039115
is	O
safe	B:C0243095
and	O
effective	O
.	O

It	O
results	O
in	O
more	O
removed	O
nodes	B:C0024204
and	O
a	O
higher	O
LN	O
positivity	O
rate	O
compared	O
to	O
SPLND	O
,	O
predicting	O
lymph	O
node	I:C1269955
invasion	I:C1269955
without	O
increasing	O
complications	O
.	O

It	O
results	O
in	O
more	O
removed	O
nodes	O
and	O
a	O
higher	O
LN	B:C0024204
positivity	O
rate	O
compared	O
to	O
SPLND	O
,	O
predicting	O
lymph	O
node	I:C1269955
invasion	I:C1269955
without	O
increasing	O
complications	O
.	O

It	O
results	O
in	O
more	O
removed	O
nodes	O
and	O
a	O
higher	O
LN	O
positivity	B:C1446409
rate	O
compared	O
to	O
SPLND	O
,	O
predicting	O
lymph	O
node	I:C1269955
invasion	I:C1269955
without	O
increasing	O
complications	O
.	O

It	O
results	O
in	O
more	O
removed	O
nodes	O
and	O
a	O
higher	O
LN	O
positivity	O
rate	O
compared	O
to	O
SPLND	B:C0193883
,	O
predicting	O
lymph	O
node	I:C1269955
invasion	I:C1269955
without	O
increasing	O
complications	O
.	O

It	O
results	O
in	O
more	O
removed	O
nodes	O
and	O
a	O
higher	O
LN	O
positivity	O
rate	O
compared	O
to	O
SPLND	O
,	O
predicting	O
lymph	B:C1269955
node	I:C1269955
invasion	I:C1269955
without	O
increasing	O
complications	O
.	O

It	O
results	O
in	O
more	O
removed	O
nodes	O
and	O
a	O
higher	O
LN	O
positivity	O
rate	O
compared	O
to	O
SPLND	O
,	O
predicting	O
lymph	O
node	I:C1269955
invasion	I:C1269955
without	O
increasing	O
complications	B:C0009566
.	O

